THERALASE TECHNOLOGIES INC./ CA88337V1004 /
23/05/2024 20:16:22 | Chg. 0.000 | Volume | Bid20:16:22 | Ask20:16:22 | High | Low |
---|---|---|---|---|---|---|
0.160CAD | 0.00% | 3,000 Turnover: 480 |
0.155Bid Size: 51,500 | 0.160Ask Size: 77,000 | 0.160 | 0.160 |
GlobeNewswire
07/02/2022
Theralase® Demonstrates Proof-of-Concept for Canadian-Made COVID-19 Vaccine
GlobeNewswire
31/08/2021
Theralase Releases Q221 Unaudited Financial Statements and Quarterly Newsletter
GlobeNewswire
11/06/2021
Theralase® Launches Seventh US-Based Clinical Study Site and Treats First Patient in the US
GlobeNewswire
21/12/2020
Life Sciences Company Investor Presentations Now Available for On-Demand Viewing
GlobeNewswire
14/12/2020
Virtual Conference for Life Sciences Companies Broadcast Live December 17th, 2020
GlobeNewswire
13/09/2017
Global Cancer Photodynamic Therapy Market & Cancer Photosensitisers Clinical Trial Report 2017-2023